Why Sequenom Shares Slumped

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Sequenom (NASDAQ: SQNM  ) , a maker of diagnostic and genetic analysis solutions, slumped by as much as 11% after reporting worse-than-expected fourth-quarter earnings results.

So what: For the quarter, Sequenom reported a big surge in revenue to $33.7 million, up 117% over the year-ago period. The biggest driver was the MaterniT21 non-invasive prenatal test for Down syndrome -- which generated $21.1 million in sales, up from $2.8 million at this time last year. However, expenses also ballooned as more tests were performed and marketing costs rose, resulting in a 3% reduction in gross margin to 37% and a loss of $0.29 per share, $0.07 worse than analysts had projected.

Now what: As usual, Sequenom can't seem to get out of its own way. There has always been plenty of promise that its genetic analysis tools would be widely incorporated into the biomedical arena, but that just hasn't been the case as of yet. While I still see Sequenom as a company that could excel over the long term as genetic products are utilized more frequently to personalize patient care, I wouldn't be surprised if it continued to underperform the broader market over the next couple of quarters.

Craving more input? Start by adding Sequenom to your free and personalized watchlist so you can keep up on the latest news with the company.

While you can certainly make huge gains in life science companies like Sequenom, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 08, 2013, at 4:00 PM, foolish07 wrote:

    Another Motley Whore puts in his 2 minutes work and files his article. A loss based on bad guesses based on limited information. Another college educated idiot that was taught nothing but to look at the numbers. You will go far now that you are a writer...

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2302560, ~/Articles/ArticleHandler.aspx, 9/20/2014 6:18:50 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement